Patients with severe asthma who initiate biologics may reduce their risk for oral corticosteroids (OCS)-related new-onset adverse outcomes.

Krystal Craddock has received a prestigious literary award for her research on a groundbreaking care model that relies on ...

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

It’s time once again to dive into another round of quick takes on the people, places and events that were being talked about ...

Balloon pulmonary angioplasty led to clinical improvements and relatively low complication rates for CTEPH patients in a ...

A multidisciplinary guideline panel convened by the American Association of Bronchology and Interventional Pulmonology (AABIP ...

Both patients with IPF and patients with PPF treated with nerandomilast demonstrated a smaller decline in forced vital ...

No significant difference in mortality was observed at 96 hours among children with severe acute malnutrition and ...

NJBIZ spotlights under-recognized health care leaders, from startup founders to behind-the-scenes pros driving innovation.

UVA Health is home to nine of the nation’s top medical specialty programs, according to Newsweek magazine. (University ...

Rates of Raynaud phenomenon medication initiation are low among patients with SSc in the United States, with less than one-third receiving consistent treatment.